Listed by:
Established in 1999, this Midwest-based “specialty” pharmacy generated over $6.5M of gross revenue, EBITDA of $475K, and SDE cash flow of $575K in FY2010. YTD2011 performance places the pharmacy on track to generate +$7.0M of gross annual revenue, and EBITDA of +$525K, SBA-adjusted Cash Flow of $585K, and SDE Cash Flow of +$745K.
Staffed with one F/T RPh, two F/T RxTechs, and one F/T General Manager, this company operates under a lean, highly efficient business plan. This is an ideal acquisition candidate for the Purchaser that is seeking to diversify/expand OR that is seeking to conduct a merger/consolidation.
Seller’s asking price of $2.9M + inventory at seller’s cost (approx. $80K) includes FF&E valued at $30,000. Funding project for this business acquisition has been pre-approved by an SBA-preferred lender with 12.5% buyer equity.
For additional information, please contact either David Hayes at ------------ Ext. 241 (---------@--------------.---) -- ---- ------ -- ------------ ---. --- (----.------@--------------.---).
For more information about this business for sale, click the Contact Seller button.
Please only contact this seller if you have a GENUINE interest in buying this business. DO NOT MAKE CONTACT if you wish to sell your third party goods or services as you will be blocked from this site.
If you own a business and are considering selling, visit our Sell a section.